The nationwide experiment will initially include around 100,000 volunteers.
A needle-free alternative to the finger-prick test would be a godsend for many sufferers of diabetes, but the industry has yet to clear the technological hurdles.
The Scientist
Most Recent
Spark Therapeutics’s Luxturna would be the first approved therapy in the U.S. that replaces or repairs a defective gene inherited from one’s parents.
Empirical data and humans’ biased interpretations can only get so far in truly understanding life at the microscale.
Vaginal birth leads to changes in the development of offsprings’ microbiomes not seen among mice born via C-section, which researchers suspect might contribute to the weight differences.
Combined transcription and genome data from multiple tissues in hundreds of human donors reveal links between genotype and gene expression across the body.
The dolphins and their trainers will search for the endangered porpoises and enclose them in a protected pen.
Studies suggest not all critters fare well in extreme weather, though some thrive.
Tissue recipients were treated as “guinea pigs,” says investigation leader.
Mice receiving the treatment produced their own monoclonal antibodies and survived infection with the life-threatening pathogen Pseudomonas aeruginosa.
Popular Now
-
The Nutshell Estonia Offers Free Genetic Testing to Residents -
Daily News Human Brain Organoids Thrive in Mouse Brains After implantation, the tissue developed blood vessels and became integrated into neuronal networks in the animals’ brains.
-
The Nutshell New Ovarian Cancer Vaccine Shows Promise A preliminary clinical trial finds that the personalized therapy improves survival rates and has no severe side-effects.
-
Daily News The Second March for Science a Smaller Affair Many cities around the globe, including Washington, DC, saw shrunken crowd sizes, and numerous events turned into rallies rather than processions.
Current Issue
© 1986-2018 The Scientist
